Health Care: Drugs

Nektar Therapeutics Inc (NKTR: NASDAQ)

$18.96 -0.775 | -3.93%
06/27/17 - 03:11 PM ET
Company Profile
Price and Volume
Recent Price 19.74
52 Week High 24.88
52 Week Low 11.41
Avg. Daily Vol. (Mil) 1.62
Beta (3 year) 2.33
Share Related Items
Mkt Cap (Mil) 3,062.65
Shares Out (Mil) 155.15
Float (Mil) 88.71
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.60
Current Ratio 4.90
LT Debt/ Equity 5.49
Total Debt / Equity 5.55
Valuation Ratios
Price Earnings n.a.
Price/Sales 23.32
Price/Book 68.42
Price/Cash Flow -16.80
Per Share Data
Earnings -1.38
Sales 0.85
Book Value 0.29
Cash Flow -1.17
Business Summary
Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company's research and development activities involve small-molecule drugs, and peptides.
General Information
455 Mission Bay Boulevard So
San Francisco, CA 94158
www.nektar.com
Industry : Drugs
Sector: Health Care
Employees: 468
CEO: Mr. Howard W. Robin
Short Interest
Current Month (Mil) 11.14
Previous Month (Mil) 10.48
Short Interest Ratio (Days) 7.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -37.40
Return on Investments -68.20
Profitability
Gross Margin 91.00
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NKTR

Latest NKTR Headlines from TheStreet

More Financial News for NKTR

Press Releases for NKTR

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter